• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Seelos Therapeutics Inc (NQ: SEEL )

    1.280 UNCHANGED
    Last Price Updated: 4:00 PM EDT, Oct 15, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Seelos Therapeutics Inc

    < Previous 1 2
    ...
    13 14 15 16 17 18 19 20 Next >
    Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2021
    Upgrades According to Roth Capital, the prior rating for Seelos Therapeutics Inc (NASDAQ: 
    Via Benzinga
    Seelos Therapeutics Shares Gain On FDA Approval To Add SLS-005 Regimen In HEALEY ALS Trial
    The Sean M. Healey & AMG Center for ALS at Mass General received approval from the FDA and the Mass General Brigham Institutional Review Board to add SLS-005 (... 
    Via Benzinga
    Exposures Product Safety
    Why Seelos Therapeutics' Stock Is Trading Higher Today
    Seelos Therapeutics (NASDAQ:SEEL) shares are trading higher. Traders are circulating a Massachusetts General Hospital report titled 'Investigational drug SLS-005 (... 
    Via Benzinga
    $10 Billion Sackler Opioid Settlement Closes Chapter, Psychedelic Chapter Begins
    Via FinancialNewsMedia
    Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry?
    By Natan Ponieman and Javier Hasse The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate... 
    Via Benzinga
    Psychedelic Drug Industry Report Card For 2021
    In assessing the psychedelic drug industry, a primary focus for investors is drug development. 
    Via Talk Markets
    25 Stocks Moving in Monday's Pre-Market Session
    Gainers Greenpro Capital Corp. (NASDAQ: GRNQ) rose 48.7% to $1.13 in pre-market trading. Greenpro Capital shares gained 16% on Friday after the company announced its Angkasa-X... 
    Via Benzinga
    Which Psychedelic Drug Stock Category Outperformed Last Week
    Which has performed best YTD, the Pure-Play Marijuana Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index? 
    Via Talk Markets
    Topics Cannabis
    Exposures Cannabis
    Field Trip Health Heads To The Nasdaq As Wall Street Opens Up To "Psychedelics Renaissance"
    Excitement around psychedelics grows as major U.S. exchanges make room for more companies in the sector. On Friday, 
    Via Benzinga
    Psychedelics Gain More Traction as New Research Aims to Address Chronic Pain and Mental Illness
    Via FinancialNewsMedia
    Topics Law Enforcement
    Exposures Legal
    How To Invest In "Magic Mushrooms" (Psychedelics)
    A look at psychedelics as stock market investment opportunities and identifying alternative strategies on how to invest. 
    Via Talk Markets
    Psychedelics Research FYI: Every Clinical Trial Underway Right Now Involving Public And Private Companies
    This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Ps... 
    Via Benzinga
    Seelos' Single Dose Of SLS-004 Shows Reduction In Parkinson's Associated mRNA, Protein Expression
    Seelos Therapeutics Inc (NASDAQ: SEEL) has announced positive in vivo data demonstrating down-regulation of SNCA mRNA and protein expression from a study of SLS-... 
    Via Benzinga
    The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 6) Ambrx Biopharma Inc. (NYSE:... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Gainers Opiant Pharmaceuticals (NASDAQ:OPNT 
    Via Benzinga
    Why Seelos Therapeutics Is Moving Today
    Seelos Therapeutics, Inc. (NASDAQ: SEEL) shares are trading higher after Guggenheim analyst Yatin Suneja initiated coverage on the stock with a Buy rating and announced an $8... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For July 1, 2021
    Upgrades Citigroup upgraded the previous rating for Thor Industries Inc (NYSE: 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Gainers Alterity Therapeutics (NASDAQ:ATHE) shares moved upwards by 60.76% to $2.09 during Thursday's pre-market session. The market value of their outstanding shares... 
    Via Benzinga
    Why Seelos Therapeutics Stock Is Jumping Today
    The company has been included in the first U.S. psychedelics-focused ETF. 
    Via The Motley Fool
    Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2021
    Upgrades For Equity Residential (NYSE:EQR), BMO Capital upgraded the previous rating of Market Perform to Outperform. Equity Residential earned $0.68 in the first quarter... 
    Via Benzinga
    Seelos's Amyotrophic Lateral Sclerosis Candidate, SLS-005 An Orphan Drug In Europe
    Seelos Therapeutics Inc's (NASDAQ: SEEL) Trehalose (SLS-005) has received Orphan Drug Designation for amyotrophic lateral sclerosis (ALS) from the European... 
    Via Benzinga
    Psyched: MindMed To Begin Mescaline Trials and Deepak Chopra Partnership, Seelos And Cybin Advance Clinical Research
    MindMed’s News Spree: Mescaline Trials, Chopra Foundation Partnership and LSD Research MindMed (NASDAQ: 
    Via Benzinga
    Increased R&D Activities Have Fueled Growth and Promise for Pancreatic Cancer Treatment
    Via FinancialNewsMedia
    Topics Death
    Exposures Death
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Gainers VistaGen Therapeutics (NASDAQ:VTGN) shares moved upwards by 14.34% to $2.63 during Thursday's pre-market session. The market value of their outstanding shares... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Gainers VistaGen Therapeutics (NASDAQ:VTGN 
    Via Benzinga
    CNS Pharmaceuticals Commences Patient Enrollment in Potentially Pivotal Study of Berubicin
    CNS Pharmaceuticals today announced open enrollment for its potentially pivotal study evaluating the efficacy and safety of Berubicin in the treatment of recurrent GBM. 
    Via Talk Markets
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Gainers Onconova Therapeutics (NASDAQ:ONTX) shares moved upwards by 41.84% to $0.88 during Tuesday's regular session. As of 12:30 EST, this security is trading at a... 
    Via Benzinga
    58 Biggest Movers From Yesterday
    Gainers BM Technologies, Inc. (NYSE: BMTX) shares climbed 26.4% to close at $11.82 on Tuesday after the company reported record Q1 results. Ultralife Corporation (NASDAQ: ULBI)... 
    Via Benzinga
    42 Stocks Moving In Tuesday's Mid-Day Session
    Gainers Agenus Inc. (NASDAQ: AGEN) shares surged 33.4% to $4.35. Bristol-Myers Squibb Co and Agenus entered into a global exclusive license agreement, under which Bristol Myers... 
    Via Benzinga
    58 Biggest Movers From Yesterday
    Gainers Peabody Energy Corporation (NYSE: BTU) shares gained 32.3% to settle at $8.60 on Monday. Nuvve Holding Corp. (NASDAQ: NVVE) shares jumped 30.9% to close at $10.80 on... 
    Via Benzinga
    < Previous 1 2
    ...
    13 14 15 16 17 18 19 20 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.